| Laboratory of Pharmacoepidemiology | |
| Lab page | Japanese | |
|
|
|
 |
Publication List (Journals) |
|
1.
|
Morita, T., Honma, M. and Morikawa, K.: Effect of reducing the top concentration used in the in vitro chromosomal aberration test in CHL cells on the evaluation of industrial chemical genotoxicity. Mutation Research, 741:32-56 (2012). |
|
2.
|
Nakaoka, S., Ishizaki, T., Urushihara, H., Satoh, T., Ikeda, S., Morikawa, K., Nakayama, T. Adherence in performing echocardiography to detect valvulopathy associated with the use of ergot-derived dopamine agonists in patients with Parkinson’s disease: Internal Medicine,50, 687-694（2011). |
|
3.
|
Kubota, K., Kasuga, F., Iwasaki, E., Inagaki, S., Sakurai, Y., Komatsu, M., Toyofuku, H., Angulo, F.J., Scallan, E., Morikawa, K.: Estimating the burden of acute gastroenteritis and foodborne illness caused by Campylobacter, Salmonella and Vibrio parahaemolyticus by using population-based telephone survey data, Miyagi Prefecture, Japan, 2005 to 2006. Journal of Food Protection, 74(10):1592-1598 (2011). |
|
4.
|
Morita, T. and Morikawa, K.: Expert Review for GHS Classification of Chemicals on Health Effects, Industrial Health, 49(5): 559-565（2011). |
|
5.
|
Morita, T., Hayashi, M., Nakajima, M., Tanaka, N, Tweats, D.J., Morikawa, K. and Sofuni, T.: Practical Issues on the Application of the GHS Classification Criteria for Germ Cell Mutagens, Regul. Toxicol. Pharmacol., 55, 52-68 (2009). |
|
6.
|
Kubota, K., Iwasaki, E., Inagaki, S., Nokubo, T., Sakurai, Y., Komatsu, M., Toyofuku, H., Kasuga, F., Angulo, F.J., Morikawa, K.: The Human Health Burden of Foodborne Infections Caused by Campylobacter, Salmonella, and Vibrio parahaemolyticus in Miyagi Prefecture, Japan, Foodborne Pathog Dis. 5(5):641-648 (2008). |
|
7.
|
Katayama,H., Higo,T., Tokunaga,Y. Hiyama,Y., Morikawa, K. Monitoring Minimization of Grade B Environments Based on Risk Assessment Using Three-Dimensional Airflow Measurements and Computer Simulation: J. Pharm Sci Technol., 62, 244-255 (2008). |
|
8.
|
Uneyama C, Toda M, Yamamoto M, Morikawa, K.: Arsenic in various foods: cumulative data. Food Addit Contam., 24, 447-534 (2007). |
|
9.
|
Morita,T., Hayashi,M., Morikawa, K.: Globally Harmonized System on hazard classification and labeling of chemicals and Other Existing Classification Systems for Germ Cell Mutagens, Genes and Environment, 28, 141-152 (2006). |
|
10.
|
Katayama, H., Higo, T., Tokunaga, Y., Hiyama, Y., Morikawa, K. Establishment of Critical Contamination Risk Locations (“Hot Spots”) in Environmental Monitoring by Means of Three-Dimensional Airflow Analysis and Particulate Evaluation: J. Pharm Sci Technol., 59, 49-63 (2005). |
|
11.
|
Yamamoto,M., Onodera,R., Yamamoto,N., Morikawa, K.：Unique situation of consumption of prescription drugs for gastroduodenal ulcer, gastroesophageal reflux disease (GERD) and other gastrointestinal disorders in Japan during 1996 -2000. : A comparative study with Norway, J.Appl Ther Res, 5, 31-36 (2004). |
|
12.
|
Suzuki K, Hosaka S, Morikawa, K., Suzuki S, Miyoshi M, Fujita M, Mizuno S. Bioimaging of myeloperoxidase release into phagolysosome of viable polymorphonuclear leukocytes and reaction of the enzyme with microspheres using a highly sensitive analyzer system, IRMAS. : Bioimages, 1, 13-20 (1993). |
|
13.
|
Fujita,M., Morikawa, K. Regional differences in dietary intake of environmental pollutants in Japan.: J. of Exposure Analysis and Environmental Epidemiology, 2, 177-193 (1992). |
|
14.
|
Kinoshita,K., Morikawa, K., Fujita,M., Natori,S Inhibitory effects of plant secondary metabolites on cytotoxic activity of polymorphonuclear leukocytes.: Planta Medica 58, 117-228 (1992). |
|
15.
|
Hiraoka, M., Takizawa, Y., Masuda, Y, Takeshita, R., Yagome, K., Tanaka, M., Watanabe, I., and Morikawa, K. Investigation on Generation of Dioxins and Related Compounds from Municipal Incinerators in Japan. : Chemosphere, 16: 1901-1906 (1987). |
|
16.
|
Fujita,M., Morikawa, K. Regional differences in dietary intake of environmental pollutants in Japan.: J. of Exposure Analysis and Environmental Epidemiology, 2, 177-193 (1992). |
|
17.
|
Morikawa, K., Sato, T., Nakazawa, H., and Fujita, M. Calcium-independent Induction of Cytocidal Activity of olymorphonuclear Leukocytes by Phorbol Myristate Acetate-like Tumor Promoters. : Life Sciences, 38: 1073-1079 (1986) |
|
18.
|
Morikawa, K., Noguchi,T., Yamazaki,M.,and Mizuno, D. Calcium-dependent and -independent Tumoricidal Activity of Polymorphonuclear Leukocytes Induced by a Linear β-1,3-D-Glucan and Phorbol Myristate Acetate. : Cancer Research, 46: 66-70 (1986) |
|
19.
|
Morikawa, K., Kamegaya, S., Yamazaki, M., and Mizuno, D. Hydrogen Peroxide as a Tumoricidal Mediator of Polymorphonuclear Leukocytes Induced by a Linear β-1,3-D-Glucan and Some Other Immunomodulators. : Cancer Research, 45: 3482-3486 (1985) |
|
20.
|
Morikawa, K., Takeda, R., Yamazaki, M., and Mizuno, D. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear β-1,3-D-glucan and other immunomodulators in murine cells. : Cancer Research, 45: 1496-1501 (1985) |
|
21.
|
Morikawa, K., Kikuchi, Y., Abe, S., Yamazaki, M., and Mizuno, D. Early Cellular Responses in the Peritoneal Cavity of Mice to Antitumor Immunomodulators. : Gann, 75: 370-378 (1984) |
|
Publication List (Books) |
|
|
|